U.S. Doctors Becoming Skeptical of Indian Generic Drugs

U.S. Doctors Becoming Skeptical of Indian Generic Drugs

U.S. doctors are becoming quite skeptical of generic drugs coming from the country of India, a report from Reuters indicates. They are reportedly becoming ever more nervous regarding the quality of the Indian drugs being used in U.S. hospitals today.

There have reportedly been many Food and Drug Administration (FDA) bans and recalls on drugs coming from the manufacturers based there already and this has doctors concerned. The Reuters report claims that Indian generic and over-the-counter drug manufacturers hold 40 percent of that market, but the recalls are bad news for their legal drug business aimed at U.S. hospitals and doctors. Some of the cited issues reportedly involved sanitation and data manipulation. Canada still supplies more of the generic drugs to the U.S.

In the United States, about 85 percent of drugs administered by health care professionals are generic, according to Reuters, and the federal government seeks to use those savings to control health care costs in the country. Indian trade groups representing the generic drug industries there defend their manufacturing techniques and claim they are just as safe as other countries.

Tags: